Skip to content

BelCoPhar: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BelCoPhar

BE 0789.518.434
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€28,535
2024 · €57,280-€28,745
Equity
€176,428
2024 · €147,892+€28,535
Cash
€115,872
2024 · €71,425+€44,447
Balance sheet total
€224,468
2024 · €196,436+€28,031

Largest movements

2024 to 2025
Assets
  • Cash +€44,447

    up €44,447 (+62.2%), from €71,425 to €115,872

    mainly Net result for the year (+€28,535) and Receivables within one year (+€22,560)

  • Receivables within one year -€22,560

    down €22,560 (-35.8%), from €62,940 to €40,380

    of which Trade receivables: -€23,513

  • Deferred charges and accrued income +€10,389

    new in 2025: €10,389

  • Tangible fixed assets -€4,245

    down €4,245 (-6.8%), from €62,071 to €57,826

    of which Furniture and vehicles: -€13,316

Equity and liabilities
  • Profit (loss) carried forward +€28,535

    up €28,535 (+20.1%), from €141,892 to €170,428

  • Tax, wage and social debts -€11,141

    down €11,141 (-23.5%), from €47,371 to €36,230

  • Trade debts +€8,167

    up €8,167 (+697%), from €1,172 to €9,340

  • Accrued charges and deferred income +€2,470

    new in 2025: €2,470

Income statement
  • Gross operating margin -€25,465

    down €25,465 (-30.9%), from €82,338 to €56,874

  • Depreciation +€9,851

    up €9,851 (+218%), from €4,510 to €14,362

  • Taxes -€9,792

    down €9,792 (-51.1%), from €19,148 to €9,356

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €57,280
Gross operating margin -€25,465
Depreciation -€9,851
Other operating charges +€63
Other operating items -€3,540
Financial income +€91
Financial charges +€164
Taxes +€9,792
Result 2025 €28,535
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€54,564
Investment -€10,117
Financing €0
Cash 2024 €71,425
Net result for the year +€28,535
Depreciation +€14,362
Receivables within one year +€22,560
Deferred charges and accrued income -€10,389
Trade debts +€8,167
Tax, wage and social debts -€11,141
Accrued charges and deferred income +€2,470
Investment in fixed assets (net) -€10,117
Cash 2025 €115,872
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €196,436 €224,468 +€28,031 +14.3%
Fixed assets 21/28 €62,071 €57,826 -€4,245 -6.8%
Tangible fixed assets 22/27 €62,071 €57,826 -€4,245 -6.8%
Plant, machinery and equipment 23 - €9,072 +€9,072
Furniture and vehicles 24 €62,071 €48,755 -€13,316 -21.5%
Current assets 29/58 €134,365 €166,641 +€32,276 +24.0%
Amounts receivable within one year 40/41 €62,940 €40,380 -€22,560 -35.8%
Trade receivables 40 €60,921 €37,408 -€23,513 -38.6%
Other amounts receivable 41 €2,019 €2,972 +€953 +47.2%
Cash at bank and in hand 54/58 €71,425 €115,872 +€44,447 +62.2%
Deferred charges and accrued income 490/1 - €10,389 +€10,389
Total equity and liabilities 10/49 €196,436 €224,468 +€28,031 +14.3%
Equity 10/15 €147,892 €176,428 +€28,535 +19.3%
Contributions 10/11 €6,000 €6,000 = 0.0%
Profit (loss) carried forward 14 €141,892 €170,428 +€28,535 +20.1%
Amounts payable 17/49 €48,544 €48,040 -€504 -1.0%
Amounts payable within one year 42/48 €48,544 €45,570 -€2,974 -6.1%
Trade debts 44 €1,172 €9,340 +€8,167 +697%
Suppliers 440/4 €1,172 €9,340 +€8,167 +697%
Taxes, remuneration and social security 45 €47,371 €36,230 -€11,141 -23.5%
Taxes 450/3 €47,371 €36,230 -€11,141 -23.5%
Accrued charges and deferred income 492/3 - €2,470 +€2,470
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,510 €14,362 +€9,851 +218%
Other operating charges 640/8 €687 €624 -€63 -9.2%
Non-recurring operating charges 66A - €3,540 +€3,540
Gross operating margin 9900 €82,338 €56,874 -€25,465 -30.9%
Operating profit (loss) 9901 €77,141 €38,348 -€38,793 -50.3%
Financial income 75/76B €30 €121 +€91 +304%
Recurring financial income 75 €30 €121 +€91 +304%
Financial charges 65/66B €743 €578 -€164 -22.1%
Recurring financial charges 65 €743 €578 -€164 -22.1%
Profit (loss) for the period before taxes 9903 €76,428 €37,891 -€38,537 -50.4%
Income taxes 67/77 €19,148 €9,356 -€9,792 -51.1%
Profit (loss) for the period 9904 €57,280 €28,535 -€28,745 -50.2%
Profit (loss) for the period to be appropriated 9905 €57,280 €28,535 -€28,745 -50.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.